Anchor Capital Advisors LLC Sells 20,334 Shares of GE HealthCare Technologies Inc. $GEHC

Anchor Capital Advisors LLC reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 672,973 shares of the company’s stock after selling 20,334 shares during the quarter. GE HealthCare Technologies accounts for about 1.6% of Anchor Capital Advisors LLC’s investment portfolio, making the stock its 13th largest holding. Anchor Capital Advisors LLC’s holdings in GE HealthCare Technologies were worth $55,197,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Allstate Corp boosted its position in shares of GE HealthCare Technologies by 100.3% in the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after acquiring an additional 16,365 shares during the period. Temasek Holdings Private Ltd bought a new position in GE HealthCare Technologies in the 3rd quarter valued at $99,922,000. Envestnet Asset Management Inc. grew its position in shares of GE HealthCare Technologies by 15.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after purchasing an additional 46,231 shares in the last quarter. Sound Shore Management Inc CT grew its position in shares of GE HealthCare Technologies by 14.6% during the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock valued at $73,655,000 after purchasing an additional 125,062 shares in the last quarter. Finally, Waverton Investment Management Ltd increased its holdings in shares of GE HealthCare Technologies by 2.8% in the third quarter. Waverton Investment Management Ltd now owns 1,086,668 shares of the company’s stock worth $81,582,000 after purchasing an additional 29,897 shares during the period. 82.06% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Wells Fargo & Company decreased their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research note on Thursday, April 30th. JPMorgan Chase & Co. lowered their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research report on Thursday, April 30th. Citigroup dropped their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Rothschild & Co Redburn reduced their target price on GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Finally, The Goldman Sachs Group downgraded GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their price target for the company from $81.00 to $65.00 in a research report on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $80.21.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $61.99 on Wednesday. The company has a market capitalization of $28.20 billion, a P/E ratio of 14.83, a PEG ratio of 1.41 and a beta of 0.74. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The stock has a 50 day moving average price of $67.53 and a two-hundred day moving average price of $75.81.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s revenue was up 7.4% on a year-over-year basis. During the same period last year, the company posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kevin Lobo bought 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average price of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at $921,817.34. This represents a 229.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders purchased 21,847 shares of company stock worth $1,361,355. Corporate insiders own 0.36% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.